EUVIMEDEUVIMED entdecken
Crossref

Biocatalytic Production of a Key Chiral Intermediate of the HIV Capsid Inhibitor Lenacapavir

Grayson J Ford, Christopher J Taylor, Amy E Hutton, William R Birmingham iD, Fei Zhao, Zefei Xu, William Finnigan, Mary Ortmayer iD, Colin W Levy, Mark S Dunstan iD, Rebecca Crawshaw iD, Ian Rowles und 2 weitere

Journal of the American Chemical Society · 22.04.2026 · 148 (15) · 15384-15390

DOI: 10.1021/jacs.6c02519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.04.2026. Verfasst von Grayson J Ford und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K. Hauptthemen laut MEDLINE: Transaminases, Anti-HIV Agents, Capsid, Valine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Tianjin Institute of Industrial Biotechnology Chinese Academy of Sciences (TIB-CAS), Henry Royce Institute for Advanced Materials, Development of a national facility and technical training hub for ?Biomolecule Engineering?.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransaminasesAnti-HIV AgentsCapsidValineBiocatalysisStereoisomerismMolecular StructureAcetamidesIndazoles

Substanzen

TransaminasesAnti-HIV AgentsValinelenacapavirAcetamidesIndazoles

Autor:innen und Institutionen

  • Department of Chemistry, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
  • Disyn Biotec Ltd., Manchester Institute of Biotechnology, 131 Princess Street, Manchester M1 7DN, U.K.

ORCID-Profile: William R Birmingham, Mary Ortmayer, Mark S Dunstan, Rebecca Crawshaw, Anthony P Green, Nicholas J Turner

Förderung

  • Tianjin Institute of Industrial Biotechnology Chinese Academy of Sciences (TIB-CAS)
  • Henry Royce Institute for Advanced Materials
  • Development of a national facility and technical training hub for ?Biomolecule Engineering?
  • Future Biomanufacturing Hub
  • National Natural Science Foundation of China (NSFC)
  • Manchester SYNBIOCHEM Centre
  • Gates Foundation

Zitieren

APA

Ford, G. J., Taylor, C. J., Hutton, A. E., Birmingham, W. R., Zhao, F., Xu, Z., Finnigan, W., Ortmayer, M., Levy, C. W., Dunstan, M. S., Crawshaw, R., Rowles, I., Green, A. P., & Turner, N. J. (2026). Biocatalytic Production of a Key Chiral Intermediate of the HIV Capsid Inhibitor Lenacapavir. Journal of the American Chemical Society, 148(15), 15384-15390. https://doi.org/10.1021/jacs.6c02519

Vancouver

Ford GJ, Taylor CJ, Hutton AE, Birmingham WR, Zhao F, Xu Z, et al. Biocatalytic Production of a Key Chiral Intermediate of the HIV Capsid Inhibitor Lenacapavir. Journal of the American Chemical Society. 2026;148(15):15384-15390. doi:10.1021/jacs.6c02519

BibTeX
@article{Ford2026,
  author = {Ford, Grayson J and Taylor, Christopher J and Hutton, Amy E and Birmingham, William R and Zhao, Fei and Xu, Zefei and Finnigan, William and Ortmayer, Mary and Levy, Colin W and Dunstan, Mark S and Crawshaw, Rebecca and Rowles, Ian and Green, Anthony P and Turner, Nicholas J},
  title = {Biocatalytic Production of a Key Chiral Intermediate of the HIV Capsid Inhibitor Lenacapavir},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {15},
  pages = {15384--15390},
  doi = {10.1021/jacs.6c02519}
}
Kostenlos starten →